Profile | GDS4284 / 1562426_a_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 125.225 | 41 |
GSM687648 | Patient 402 control | 192.305 | 48 |
GSM687653 | Patient 403 control | 84.4583 | 32 |
GSM687658 | Patient 404 control | 164.54 | 44 |
GSM687663 | Patient 411 control | 49.776 | 21 |
GSM687668 | Patient 422 control | 130.05 | 40 |
GSM687673 | Patient 424 control | 99.5927 | 33 |
GSM687678 | Patient 425 control | 217.034 | 49 |
GSM687683 | Patient 427 control | 213.583 | 48 |
GSM687688 | Patient 428 control | 313.996 | 56 |
GSM687695 | Patient 441 control | 255.146 | 45 |
GSM687699 | Patient 443 control | 85.8715 | 28 |
GSM687704 | Patient 444 control | 160.621 | 44 |
GSM687707 | Patient 448 control | 374.869 | 58 |
GSM687712 | Patient 449 control | 124.161 | 38 |
GSM687719 | Patient 450 control | 299.166 | 53 |
GSM687724 | Patient 451 control | 367.837 | 59 |
GSM687728 | Patient 452 control | 49.2523 | 21 |
GSM687646 | Patient 401 treated 24h | 140.646 | 41 |
GSM687649 | Patient 402 treated 24h | 90.7236 | 35 |
GSM687665 | Patient 411 treated 24h | 53.4578 | 22 |
GSM687651 | Patient 402 treated 4 weeks | 128.055 | 38 |
GSM687667 | Patient 411 treated 4 weeks | 194.14 | 47 |
GSM687670 | Patient 422 treated 24h | 172.672 | 44 |
GSM687671 | Patient 422 treated 4 weeks | 208.26 | 50 |
GSM687654 | Patient 403 treated 24h | 204.58 | 51 |
GSM687675 | Patient 424 treated 24h | 301.718 | 54 |
GSM687685 | Patient 427 treated 24h | 142.039 | 41 |
GSM687656 | Patient 403 treated 4 weeks | 182.605 | 49 |
GSM687677 | Patient 424 treated 4 weeks | 277.355 | 54 |
GSM687687 | Patient 427 treated 4 weeks | 29.4707 | 18 |
GSM687692 | Patient 428 treated 4h | 183.297 | 46 |
GSM687716 | Patient 449 treated 4h | 152.768 | 44 |
GSM687722 | Patient 450 treated 4h | 305.192 | 54 |
GSM687680 | Patient 425 treated 24h | 110.064 | 36 |
GSM687690 | Patient 428 treated 24h | 62.1591 | 26 |
GSM687700 | Patient 443 treated 24h | 372.627 | 55 |
GSM687705 | Patient 444 treated 24h | 210.221 | 51 |
GSM687714 | Patient 449 treated 24h | 102.605 | 37 |
GSM687721 | Patient 450 treated 24h | 373.757 | 57 |
GSM687682 | Patient 425 treated 4 weeks | 43.7762 | 22 |
GSM687694 | Patient 428 treated 4 weeks | 140.922 | 43 |
GSM687702 | Patient 443 treated 4 weeks | 186.303 | 44 |
GSM687718 | Patient 449 treated 4 weeks | 96.1356 | 33 |
GSM687723 | Patient 450 treated 4 weeks | 161.936 | 43 |
GSM687661 | Patient 404 treated 4h | 169.738 | 44 |
GSM687710 | Patient 448 treated 4h | 52.9045 | 24 |
GSM687726 | Patient 451 treated 4h | 224.989 | 48 |
GSM687730 | Patient 452 treated 4h | 1020.3 | 74 |
GSM687660 | Patient 404 treated 24h | 233.314 | 48 |
GSM687697 | Patient 441 treated 24h | 456.399 | 60 |
GSM687709 | Patient 448 treated 24h | 262.004 | 52 |
GSM687725 | Patient 451 treated 24h | 243.35 | 49 |
GSM687729 | Patient 452 treated 24h | 276.562 | 50 |
GSM687727 | Patient 451 treated 4 weeks | 303.399 | 54 |
GSM687731 | Patient 452 treated 4 weeks | 75.0014 | 26 |